CPUC A. 10-11-002Non-Dislosure Agreement • January 25th, 2015
NON-DISLOSURE AGREEMENTNon-Dislosure Agreement • October 31st, 2019
This Non-Disclosure Agreement (the “Agreement”) is entered into between [COMPANY] headquartered at [ADDRESS] (collectively with its direct and indirect subsidiaries, the “Company” or “you”) and Cronkhite Capital Group, LLC, headquartered at 1505 11th Street NW, Suite 2, Washington, DC, 20001 (“Cronkhite” or “us”). In connection with a potential investment in or acquisition of the Company (the “Proposed Transaction”), it is anticipated that you will disclose to us information which is confidential and proprietary to you and which is important in the conduct of your business. We understand that you will not disclose such information to us unless we agree as set forth below. Accordingly, we agree as follows:
NON DIS⏴LOSURE AGREEMENTNon Dis⏴losure Agreement • January 19th, 2022
NON-DISLOSURE AGREEMENTNon-Dislosure Agreement • October 30th, 2023
Upon receipt of information concerning ODS Medical inc. ("ODS") and any other information that may be transmitted by MNP Ltd, its employees, representatives or agents concerning ODS:
M&A PORTNon-Dislosure Agreement • April 20th, 2022
Deloitte does not recommend the use of this sample agreement for any specific business case and provides it for information purposes only.
